Testing effectiveness (Phase 2)Study completedNCT02278133
What this trial is testing
Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations
Who this might be right for
Metastatic Colorectal Cancer
Array BioPharma 20